연구동향 분석

Suppression of experimental choroidal neovascularization in a rat model by a telomerase-derived peptide vaccine = 실험적 맥락막신생혈관 쥐 모델에서 텔로머레이즈 유래 펩타이드 백신의 억제효과

이은경 2021년

논문상세정보
인용/피인용
' Suppression of experimental choroidal neovascularization in a rat model by a telomerase-derived peptide vaccine = 실험적 맥락막신생혈관 쥐 모델에서 텔로머레이즈 유래 펩타이드 백신의 억제효과' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의료과학 약
  • Telomerase
  • NF-κB 경로
  • age-related macular degeneration
  • choroidalneovascularization
  • gv1001
  • nf-κb pathway
  • peptide
  • vaccine
  • 맥락막신생혈관
  • 백신
  • 연령관련황반변성
  • 텔로머레이즈
  • 펩타이드
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
4,391 0

0.0%

' Suppression of experimental choroidal neovascularization in a rat model by a telomerase-derived peptide vaccine = 실험적 맥락막신생혈관 쥐 모델에서 텔로머레이즈 유래 펩타이드 백신의 억제효과' 의 참고문헌

  • Tumor-suppressive effect of a telomerasederived peptide by inhibiting hypoxia-induced HIF-1alpha-VEGF signaling axis
    Kim BKKim BRLee HJ Biomaterials [2014]
  • The heat shock proteins
    Lindquist SCraig EA Annu Rev Genet [1988]
  • The critical role of ocularinfiltrating macrophages in the development of choroidal neovascularization
    Tsutsumi CSonoda KHEgashira K J Leukoc Biol [200374:25-32]
  • The NF-kappa B and I kappa B proteins : new discoveries and insights
    Baldwin ASJr . Annu Rev Immunol [1996]
  • The Anti-inflammatory Effect of GV1001 Mediated by the Downregulation of ENO1-induced Pro-inflammatory Cytokine Production
    Choi JKim HKim Y Immune Netw [2015]
  • The Anti-Inflammatory Effect of Human Telomerase-Derived Peptide on P. gingivalis Lipopolysaccharide-Induced Inflammatory Cytokine Production and Its Mechanism in Human Dental Pulp Cells
    Ko YJKwon KYKum KY Mediators Inflamm [20152015:385127]
  • TelomeraseGV1001 ) vaccination together with gemcitabine in advanced pancreatic cancer patients
    Staff CMozaffari FFrodin JE Int J Oncol [201445:1293-303]
  • Telomerase peptide vaccination of patients with non-resectable pancreatic cancer : A dose escalating phase I/II study
    Bernhardt SLGjertsen MKTrachsel S Br J Cancer95:1474-82 [2006]
  • Telomerase peptide vaccination in NSCLC : a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial
    Brunsvig PFKyte JAKersten C Clin Cancer Res17:6847-57 [2011]
  • Telomerase peptide vaccination combined with temozolomide : a clinical trial in stage IV melanoma patients
    Kyte JAGaudernack GDueland S Clin Cancer Res17:4568-80 [2011]
  • Telomerase peptide vaccination : a phase I/II study in patients with non-small cell lung cancer
    Brunsvig PFAamdal SGjertsen MK Cancer Immunol Immunother55:1553-64 [2006]
  • Telomerase catalytic subunit homologs from fission yeast and human
    Nakamura TMMorin GBChapman KB Science [1997277:955-9]
  • Telomerase and cancer therapeutics
    Harley CB Nat Rev Cancer8:167-79 [2008]
  • Specific association of human telomerase activity with immortal cells and cancer
    Kim NWPiatyszek MAProwse KR Science266:2011-5 [1994]
  • Short dysfunctional telomeres impair tumorigenesis in the INK4a ( delta2/3 ) cancer-prone mouse
  • Reduction of ischaemia-reperfusion injury in a rat lung transplantation model by low-concentration GV1001
    Chang JEKim HJYi E , Eur J Cardiothorac Surg50:972-79 [2016]
  • Protein misassembly : macromolecular crowding and molecular chaperones
    Ellis RJ Adv Exp Med Biol [2007]
  • Protective effect of telomerasebased 16-mer peptide vaccine ( GV1001 ) on inferior epigastric island skin flap survivability in ischaemia-reperfusion injury rat model
    Lee YKNata'atmaja BSKim BH J Plast Surg Hand Surg [201751:210-16]
  • Protective effect of peptide GV1001 against renal ischemia-reperfusion injury in mice
    Koo TYYan JJYang J Transplant Proc [201446:1117-22]
  • Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment
    Krzystolik MGAfshari MAAdamis AP Arch Ophthalmol [2002120:338-46]
  • Possible therapy for age-related macular degeneration using human telomerase
    Rowe-Rendleman CGlickman RD Brain Res Bull [2004]
  • Novel vaccine peptide GV1001 effectively blocks beta-amyloid toxicity by mimicking the extra-telomeric functions of human telomerase reverse transcriptase
    Park HHLee KYKim S Neurobiol Aging [201435:1255-74]
  • New treatment options for advanced pancreatic cancer
    Middleton GGhaneh PCostello E , Expert Rev Gastroenterol Hepatol2:673-96 [2008]
  • Neckers L. Extracellular heat shock protein 90 : a role for a molecular chaperone in cell motility and cancer metastasis
    Tsutsumi S Cancer Sci98:1536-9 [2007]
  • Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization
    Izumi-Nagai KNagai NOhgami K Arterioscler Thromb Vasc Biol [2007]
  • Linking functional decline of telomeres , mitochondria and stem cells during ageing
    Sahin EDepinho RA Nature464:520-8 [2010]
  • Lim C. Protective effects of GV1001 on myocardial ischemiareperfusion injury
    Chang JEKim HJJheon S Mol Med Rep. [2017]
  • Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 ( STAT3 ) promotes choroidal neovascularization
    Izumi-Nagai KNagai NOzawa Y Am J Pathol [2007170:2149-58]
  • Interleukin-1beta inhibition prevents choroidal neovascularization and does not exacerbate photoreceptor degeneration
    Lavalette SRaoul WHoussier M Am J Pathol [2011178:2416-23]
  • Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice
    Yamada KSakurai EItaya M Invest Ophthalmol Vis Sci [2007]
  • Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin
    Izumi-Nagai KNagai NOhgami K Invest Ophthalmol Vis Sci [2008]
  • Inhibition of TNF-alpha reduces laserinduced choroidal neovascularization
    Shi XSemkova IMuther PS Exp Eye Res [2006]
  • Induction of Heat Shock Protein 70 in Mouse RPE as an In Vivo Model of Transpupillary Thermal Stimulation
    Amirkavei MPitkanen MKaikkonen O , Int J Mol Sci21 [2020]
  • Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections
    Cheung CSWong AWLui A Ophthalmology119:1609-14 [2012]
  • Immuno-histochemical detection of human telomerase catalytic component , hTERT , in human colorectal tumor and nontumor tissue sections
    Tahara HYasui WTahara E Oncogene [1999]
  • Henkel T. Function and activation of NF-kappa B in the immune system
    Baeuerle PA Annu Rev Immunol [1994]
  • Heat shock protein-mediated cell penetration and cytosolic delivery of macromolecules by a telomerase-derived peptide vaccine
    Lee SAKim BRKim BK Biomaterials [201334:7495-505]
  • GV1001 immunotherapy ameliorates joint inflammation in a murine model of rheumatoid arthritis by modifying collagenspecific T-cell responses and downregulating antigen-presenting cells
    Choi IAChoi JYJung S Int Immunopharmacol [201746:186-93]
  • Extracellular roles for the molecular chaperone
    Eustace BKJay DG hsp90 . Cell Cycle [2004]
  • Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer
    Shaw VENaisbitt DJCostello E Expert Rev Vaccines9:1007-16 [2010]
  • Complications of intravitreal injections
    Sampat KMGarg SJ Curr Opin Ophthalmol [2010]
  • Cohen N. Cell surface expression of the endoplasmic reticular heat shock protein gp96 is phylogenetically conserved
    Robert JMenoret A J Immunol163:4133-9 [1999]
  • Celastrol regulates innate immunity response via NF-kappaB and Hsp70 in human retinal pigment epithelial cells
    Paimela THyttinen JMViiri J Pharmacol Res [201164:501-8]
  • Cancer vaccination with telomerase peptide GV1001
    Kyte JA Expert Opin Investig Drugs [200918:687-94]
  • Anti-cancer effect of GV1001 for prostate cancer : function as a ligand of GnRHR
    Kim JWYadav DKKim SJ Endocr Relat Cancer26:147- 62 [2019]
  • Advances in peptide pharmaceuticals
    Stevenson CL Curr Pharm Biotechnol [2009]
  • A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
    Greten TFForner AKorangy F BMC Cancer10:209 [2010]
  • A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides
    Suto RSrivastava PK Science269:1585-8 [1995]
  • A Comprehensive Review on Current Advances in Peptide Drug Development and Design
    Lee ACHarris JLKhanna KKHong JH Int J Mol Sci20 [2019]